Drug & supplement interaction

Focusing + Nivolumab

Nivolumab brand name: Opdivo.

No Known Interaction
Medically reviewed by · Updated June 2026 · Pair last verified Sep 20, 2026
The bottom line No known interaction

We found no known interaction between Focusing and Nivolumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Nivolumab states a food rule worth keeping to.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Focusing and Nivolumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Nivolumab and Focusing in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Focusing at all — not against Nivolumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Focusing safety at a glance

Focusing overall Not established Safety depends entirely on the specific ingredients in a given product.
Pregnancy Avoid Ingredients are unverified and unstudied in pregnancy, so it is best to avoid.
Breastfeeding Avoid Not enough safety information exists, so avoid while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Nivolumab and Focusing? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Nivolumab’s Own FDA Label Lists

This is not an interaction — none of it involves Focusing. These are the most notable effects listed in the ADVERSE REACTIONS section of Nivolumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Low magnesium Worth acting on
  • A change in thyroid levels Worth acting on
  • A stroke or mini-stroke Worth acting on
  • Severe muscle breakdown Worth acting on
  • Dehydration Worth acting on
  • Trouble swallowing Worth acting on
  • Bleeding in the gut Worth acting on
  • High potassium Worth acting on
  • Low sodium Worth acting on
  • Low blood sugar Worth acting on

Showing the 10 most notable of 67 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Nivolumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 96,645 voluntary FDA FAERS reports for Nivolumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Focusing’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Focusing side to compare — that is a limit of the record, not a statement that Focusing has no side effects.

How to take them

Some Nivolumab Products Have a Food Rule — Focusing Should Not Break It

At least one FDA label for a product containing Nivolumab says to take it on an empty stomach. Most supplements — Focusing included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Nivolumab on its own and move Focusing to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Nivolumab products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

Table 2: Recommended Dosages of Intravenous OPDIVO in Combination with Other Therapeutic Agents Indication Recommended OPDIVO Dosage Duration of Therapy Unresectable or metastatic melanoma 1 mg/kg every 3 weeks with ipilimumab 3 mg/kg In combination with ipilimumab for a maximum of 4 doses or until unacceptable toxicity, whichever occurs earlier Adult patients and pediatric patients aged 12 years

From the Dosage and Administration section of the FDA label we read for Nivolumab — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Overlapping uses

What Nivolumab Is Prescribed For, and What Focusing Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Nivolumab is a prescription medicine with approved uses on its FDA label. Focusing is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Nivolumab is prescribed for: Opdivo (nivolumab) is used to treat many types of cancer in adults, and some in patients 12 years and older. It can be used alone or in combination with other therapies depending on the cancer type and stage. Cancers it treats include melanoma (including after surgery to reduce the chance of the cancer coming back), non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma (kidney cancer), classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma (bladder cancer), colorectal cancer with specific genetic features (MSI-H or dMMR), hepatocellular carcinoma (liver cancer), esophageal cancer, gastroesophageal junction cancer, and gastric (stomach) cancer. Some uses require the tumor to test positive for a protein called PD-L1, and some are specific to certain stages of disease or prior treatments received.

Read the rest of what Nivolumab is prescribed for

Your oncologist will determine which use applies to your situation.

Focusing has been studied for:

  • Cancer studied, not established Focusing has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Focusing for cancer

    A small clinical study in cancer patients shows that practicing focusing for 6 months decreases depression and improves attitude, but does not affect energy, activity level, or mortality. Clinical research in patients who have undergone breast cancer surgery shows that two phone sessions of Attentional Focus and Symptom Management Intervention (AFSMI) improves mood and reduces confusion, but does not have an effect o…

    2 sources cited
    1. 21077. Katonah, D. G. and Flaxman, J. Focusing: An Adjunct Treatment for Adaptive Recovery from Cancer. The Folio 1999;18(1).
    2. 21073. Allard, N. C. Day surgery for breast cancer: effects of a psychoeducational telephone intervention on functional status and emotional distress. Oncol Nurs Forum 2007;34(1):133-141. PubMed

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Nivolumab on your own; if you are taking Focusing for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Nivolumab

This page covers Focusing only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Nivolumab page lists 1 supplement it has a documented interaction with, worst first, each one explained.

The most serious there right now: American Pawpaw (minor).

By severity: 1 minor.

From our pharmacist’s overview on the Nivolumab page

“Nivolumab (Opdivo) is an immunotherapy infusion that trains the body's own immune system to recognize and attack cancer cells, the kind of drug you might expect to carry a long list of supplement warnings. It does not.”

Reviewed by 2 · Jul 18, 2026

Open the Nivolumab interaction page

How much people look this up

Where Focusing and Nivolumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Focusing
Steady interest

#795 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Nivolumab
Top 25%

#614 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Focusing reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Focusing and Nivolumab records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Focusing

What is Focusing?

  • Concentration and attention
  • Mental clarity
  • Memory support
  • Studying or work productivity
  • Reducing mental fatigue

"Focusing" is not a single herb or recognized plant — it is a marketing term used for blended supplements that claim to support concentration and mental clarity. Because the exact ingredients differ by brand, there is no single set of evidence, dose, or safety profile, so you must read each product's label carefully. Talk to a pharmacist or doctor before using any focus supplement, especially if you take other medicines or have a health condition.

Capsules, tablets, powders, drink mixes (usually blended formulas)

An interaction check asks whether these two react with each other — it does not ask whether Focusing is a good idea for someone in your situation. Here is what our Focusing record says about it on its own.

Focusing: dosing

There is no established standard dose for "Focusing," because it is not a single defined ingredient. Dosing depends entirely on the specific product and its ingredients.Follow the directions on the product label and do not exceed the recommended amount. Be especially mindful of total caffeine from all sources.

From our Focusing monograph — the full record covers uses, side effects and every documented interaction.

Read the full Focusing monograph & all interactions
Medication

About Nivolumab Injection

What Is Nivolumab Injection Used For?

Brand name: Opdivo

Opdivo (nivolumab) is used to treat many types of cancer in adults, and some in patients 12 years and older. It can be used alone or in combination with other therapies depending on the cancer type and stage. Cancers it treats include melanoma (including after surgery to reduce the chance of the cancer coming back), non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma (kidney cancer), classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma (bladder cancer), colorectal cancer with specific genetic features (MSI-H or dMMR), hepatocellular carcinoma (liver cancer), esophageal cancer, gastroesophageal junction cancer, and gastric (stomach) cancer.

Some uses require the tumor to test positive for a protein called PD-L1, and some are specific to certain stages of disease or prior treatments received. Your oncologist will determine which use applies to your situation.

Most-Reported Side Effects for Nivolumab

From FAERS, the FDA’s public side-effect reporting system (96,645 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Malignant neoplasm progression 9,878 reports
Diarrhea 5,251 reports
Fatigue 4,195 reports
Fever 3,721 reports
Nausea 3,182 reports
See full Nivolumab Injection drug information
Keep checking

Other Drugs & Focusing

Browse every other medication we’ve checked against Focusing — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
2,829 No interaction
No interaction 2,829 drugs checked — show the list

We also checked Focusing against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Focusing list.

See the full Focusing interactions page
See every supplement checked against Nivolumab, ranked by severity
Evidence & sources

Focusing References

The 20 references that drive our Focusing monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Allard, N. C. Day surgery for breast cancer: effects of a psychoeducational telephone intervention on functional status and emotional distress. Oncol Nurs Forum 2007;34(1):133-141. PubMed
  2. Pettinati, M. D. The relative efficacy of various complementary modalities in the lives of patients with chronic pain: A pilot study. The USA Body Psychotherapy 2002;1(2):5-26.
  3. Cirstea, M. C. and Levin, M. F. Improvement of arm movement patterns and endpoint control depends on type of feedback during practice in stroke survivors. Neurorehabil .Neural Repair 2007;21(5):398-411. PubMed
  4. Klagsbrun, J., Rappaport, L., Marcow Speiser, V., Post, P., Byers, J., Stepakoff, S., and Karman, S. Focusing and expressive arts therapy as a complementary treatment for women with breast cancer. Journal of Creativity in Mental Health: The official journ DOI
  5. Katonah, D. G. and Flaxman, J. Focusing: An Adjunct Treatment for Adaptive Recovery from Cancer. The Folio 1999;18(1).
  6. Chiviacowsky S, Wulf G, Avila LTG. An external focus of attention enhances motor learning in children with intellectual disabilities. J Intellect Disabil Res. 2013;57(7):627-34. PubMed
  7. Donald J, Abbott MJ, Smith E. Comparison of attention training and cognitive therapy in the treatment of social phobia: a preliminary investigation. Behav Cogn Psychother. 2014;42(1):74-91. PubMed
  8. Landers MR, Hatlevig RM, Davis AD, Richards AR, Rosenlof LE. Does attentional focus during balance training in people with Parkinson's disease affect outcome? A randomised controlled clinical trial. Clin Rehabil. 2016;30(1):53-63. PubMed
  9. Laufer Y, Rotem-Lehrer N, Ronen Z, Khayutin G, Rozenberg I. Effect of attention focus on acquisition and retention of postural control following ankle sprain. Arch Phys Med Rehabil. 2007;88(1):105-8. PubMed
  10. Perreault ME, French KE. Differences in children's thinking and learning during attentional focus instruction. Hum Mov Sci. 2016;45:154-60. PubMed
  11. Rotem-Lehrer N, Laufer Y. Effect of focus of attention on transfer of a postural control task following an ankle sprain. J Orthop Sports Phys Ther. 2007;37(9):564-9. PubMed
  12. Schoenfeld BJ, Vigotsky A, Contreras B, et al. Differential effects of attentional focus strategies during long-term resistance training. Eur J Sport Sci. 2018;18(5):705-712. PubMed
  13. Zou JB, Hudson JL, Rapee RM. The effect of attentional focus on social anxiety. Behav Res Ther. 2007;45(10):2326-33. PubMed
  14. Aghakeshizadeh F, Letafatkar A, Thomas AC. Internal and external focus show similar effect on the gait kinematics in patients with patellofemoral pain: A randomised controlled trial. Gait Posture 2021;84:155-161. PubMed
  15. Ghanati HA, Letafatkar A, Almonroeder TG, Rabiei P. Examining the Influence of Attentional Focus on the Effects of a Neuromuscular Training Program in Male Athletes. J Strength Cond Res 2020. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Focusing and Nivolumab Together: Common Questions

Is it safe to take Focusing with Nivolumab?
We do not list a known interaction between Focusing and Nivolumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Should I take Focusing and Nivolumab at the same time of day?
At least one FDA label for a product containing Nivolumab says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Nivolumab on its own and move Focusing to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
Are Focusing and Nivolumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Focusing in each. That is a conversation for your prescriber, especially if Nivolumab is being adjusted to a target.
Does Nivolumab interact with any supplements?
Yes. Nivolumab has documented interactions with 1 supplement in our database — Focusing is not one of them. The Nivolumab interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Focusing monograph Uses, safety profile, and every drug interaction in one place Nivolumab Injection drug information The full plain-English guide to this medication Nivolumab supplement interactions Every supplement checked against Nivolumab, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 20 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Nivolumab and Focusing?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.